- Earth
Science Tech to add three full-spectrum CBD chocolate offerings to product
line
- Testing
to begin on CBD-based patent products
- Earth
Science Tech products will be available to 90,000 retail outlets
throughout U.S.
On the heels of a major decision by the U.S. Food and Drug
Administration (FDA) to approve Epidiolex, a drug derived from pure cannabidiol
(CBD), to treat seizures associated with certain forms of severe epilepsy,
Earth Science Tech, Inc. (OTC: ETST) is repositioning its line of full-spectrum
CBD offerings.
Included in this move is the announcement that the company,
along with joint venture partner Karmavore Superfoods, will be adding three
full-spectrum cannabinoid chocolate products to its CBD line. The options —
chocolate-covered mangoes, chocolate coconut peppermint cups and chocolate
caramelized quinoa crunch — will contain Earth Science Tech’s high-grade
cannabinoid oil and raw arriba nacional cacao, as well as other natural organic
superfood ingredients. The chocolates are slated to be available during the
third quarter of 2018.
In addition, Earth Science is scheduled to start testing on
three new CBD-based patent formulas beginning in late 2018 and extending into
2019. In vitro testing on its first batch of formulas will be aimed at
demonstrating the superior antioxidant properties and anti-proliferative
effects on breast cancer cells. These compelling products are designed to stop
inflammation, maintain quality of life and help prevent cancer and other
degenerative diseases.
With these highly anticipated new products on the horizon,
Earth Science is also focusing on making its products more available to
consumers. The company recently signed agreements with AATAC to offer Earth
Science’s CBD products to AATAC’s approximately 90,000 retail outlets
throughout the United States. Based on growing consumer interest in CBD and
positive response to the announcement, AATAC anticipates a high volume of
preorders.
“Our association with AATAC, which is an advisory board that
focuses on convenience stores, will give us the opportunity to open up and be
available to a market that includes every sector of the population,” Jill
Buzan, chief sales officer of ETST, stated in the news release. “This could
lead to huge exponential growth for ETST’s sales in the next few months.”
This focus on CBD products is designed to solidify Earth
Science’s position as a leader in a burgeoning CDB product markets. In the last
three years, the hemp-derived CBD market has grown from $90 million to $190
million, and The Hemp Business Journal projects $2.1 billion
in total CBD sales by 2020 (http://ibn.fm/ItwyP).
This tremendous increase comes as a result of a growing recognition of CBD’s
natural health and wellness properties, increased public acceptance and use of
the ingredient and the wider accessibility — both online and in
brick-and-mortar retail shops — of CBD products.
In addition to manufacturing, marketing and distributing
cannabinoid products to the nutraceutical and pharmaceutical markets, Earth
Science conducts R&D for low-cost, non-invasive medical devices.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
